Ceenik Exports (531119)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 1/1

Key Financials

Strengths

• Dividend yield of 4.43% provides some cash return despite operational weakness.
• Latest quarter reported a positive net profit of ₹2 Cr, with 118.61% profit growth.
• Piotroski F-score of 5/9 suggests moderate financial health rather than acute distress.
• Book value of ₹204.35 gives a tangible per-share reference point, though the stock trades at a large premium.

Concerns

• Latest quarter sales are ₹0 Cr, so the business has no core revenue to value.
• ROE of -11.27% and ROCE of -41.23% show ongoing capital destruction.
• P/E of 0.00, sales growth of 0.00%, and debt/equity N/A make conventional valuation and balance-sheet analysis impossible.
• The stock has soared from ₹189.20 to ₹909.70 in 52 weeks, leaving no margin of safety at the top of the range.

AI Analysis

Looking at Ceenik Exports, I see a business that fails most of the tests I would normally apply. The latest quarter reports zero sales and just ₹2 crore of net profit. That is not an operating engine; it is a non-operational blip, and it explains why the P/E is shown as 0.00. With return on equity at -11.27% and return on capital employed at -41.23%, this company has been destroying shareholder capital. A price-to-book ratio of 4.45 against a book value of ₹204.35 makes no sense when the business is losing money. The 118.61% profit growth flatters because the base is tiny, while sales growth is exactly 0.00%. In my experience, when a share moves from ₹189.20 to ₹909.70 in 52 weeks while the underlying company still cannot produce revenue, the price is being driven by hope, not by numbers I can trust. The dividend yield of 4.43% looks tempting, but a dividend paid by a company with negative returns on equity and capital is a signal of contentment with a poor business, not a margin of safety. The Piotroski score of 5 out of 9 is a moderate sign, but it does not overcome the absence of sales or the negative profitability ratios. I also have no disclosure of promoter holding or debt-to-equity, so I cannot complete basic due diligence. This is a ₹366 crore microcap at the top of its 52-week range. Graham taught me to buy with a margin of safety; here, the price is at the peak, the core sales line is empty, and returns are negative. I would rather miss a speculative move than invest in a story I cannot quantify. There is nothing in these numbers to justify my capital.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer